期刊文献+

血清降钙素原水平对ICU严重脓毒症患者早期诊断和病情评估的临床意义 被引量:7

Significance of Serum Procalcitonin Level in the Early Diagnosis and Disease Assessment of ICU Patients with Severe Sepsis
下载PDF
导出
摘要 目的分析血清降钙素原对ICU严重脓毒症患者早期诊断及病情评估的临床价值。方法随机抽取我院ICU自2011年12月至2013年12月收治120例脓毒症患者作为研究对象,按照病情严重程度,将其分为A组(脓毒症组,n=46)与B组(严重脓毒症组,n=74),于入院24 h内分别检测两组的血清降钙素原、白细胞计数及C反应蛋白水平,并采取APACHEⅡ评分量表评价脓毒症患者器官功能衰竭程度,分析不同指标与严重脓毒症患者早期诊断与病情评估的相关性。结果严重脓毒症患者血清PCT水平、白细胞计数、CRP、APACHEⅡ评分均显著高于A组患者(P<0.05)。74例严重脓毒症患者,1月后死亡34例,存活40例;死亡组患者的血清PCT水平、CRP、APACHEⅡ评分均明显高于存活组(P<0.05)。结论在严重脓毒症患者的早期诊断中,可将血清PCT作为评估患者病情进展的相关性指标,同时辅助APACHEⅡ量表评估,可提高严重脓毒症的检出率,为患者的早期治疗提供指导。 Objective To analyze the clinical value of serum procalcitonin(PCT) level in the early diagnosis and disease assessment of ICU patients with severe sepsis. Methods 120 cases of ICU patients with sepsis were selected and divided into group A(sepsis group, n =46) and group B(severe sepsis group, n = 74). The serum procalcitonin, blood cell count and C-reactive protein level were detected within24 h after admission. APACHE Ⅱ rating scale was used to evaluate the degree of organ failure, and the correlations between different indicators and early diagnosis and assessment were analyzed. Results The PCT level, blood cell count, CRP and APACHEⅡ score of group B were significantly higher than those of group A(P〈0.05). Among 74 cases of severe sepsis, there were 34 cases of death and 40 cases of survival after 1 month; The PCT level, blood cell count and CRP of death group were significantly higher than those of survival group(P〈0.05).Conclusions In the early diagnosis of severe sepsis, serum PCT can be used as assessment index of disease progression; Combined with APACHEⅡ scale, we can improve the detection rate of severe sepsis, and provide guidance for the early treatment.
出处 《临床医学工程》 2015年第3期333-334,共2页 Clinical Medicine & Engineering
关键词 严重脓毒症 降钙素原 诊断 预后 影响 Severe sepsis Procalcitonin Diagnosis Prognosis Influence
  • 相关文献

参考文献10

二级参考文献119

  • 1樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 2明自强,俞林明,吕银祥,王黎卫,吕少敏.生脉注射液和复方丹参注射液治疗急性脓毒性心肌病疗效观察[J].中国中西医结合急救杂志,2006,13(6):364-366. 被引量:11
  • 3陈海雁.急性危重病患者血乳酸(LACT)与血气检测的临床应用[J].临床和实验医学杂志,2007,6(7):91-91. 被引量:33
  • 4江学成.危重疾病严重程度评分临床应用和意义.中国危重病急救医学,2008,16(11):579-580.
  • 5UZZAN B, COHEN R, NICOLAS P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill aduhs and after surgery or trauma: a systematic review and meta-analysis [ J ]. Crit Care Med, 2006, 34(7) : 1996 -2003.
  • 6LEVY M M, FINK M P, MARSHALL J C, et al. 2001 SCCM/ ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med, 2003, 31(4) : 1250-1256.
  • 7BONE R C, BALK R A, CERRA F B, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992, 101(6): 1644-1655.
  • 8STOLZ D, CHRIST CRAIN M, BINGISSER R, et al. Antibiotic treatment of exacerbations of COPD : a randomized cont rolled trialcomparing procalcitonin guidance with standard therapy [ J ]. Chest, 2007, 131(1): 9-19.
  • 9MANIACI V, DAUBER A, WEISS S, et al. Procalcitonin in young febrile infants for the detection of serious bacterial infections [J]. Pediatrics, 2008, 122(4) : 701 -710.
  • 10MARUNA P, NEDELNIKOVA K, GURLICH R, et al. Physiology and genetics of procalcitonin[J]. Physiol Res, 2000, 49(Suppl 1 ) : S57-S61.

共引文献436

同被引文献61

引证文献7

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部